Navigation Links
British Scientists Discover New Protein to Treat Epilepsy and Schizophrenia

Curbing excitation through suppressing communication between the cells could be one way of treating diseases such as epilepsy and schizophrenia.

Researchers at the University of Bristol seem to have pitched upon a protein that could do the trick. The SUMO protein acts to damp down the amount of information transmitted to cells.

And so boosting the level of the protein in the brain could the key to tackling diseases such as epilepsy and schizophrenia, the Bristol scientists think.

There are 100 million nerve cells in the brain, which each have 10,000 connections, called synapses, which link to other nerves cells.

These connections chemically transmit information that control brain function via proteins called receptors. These processes are believed to be the basis of learning and memory.

In a healthy brain, synapses can modify how efficiently they work, by increasing or decreasing the amount of information transmitted.

Having too much information is a problem, but so is having too little which can cause conditions including coma.

The researchers, who carried out work on rats, found that when one type of receptor, the kainate receptor, receives a chemical signal a small protein called SUMO attaches itself.

SUMO pulls the kainate receptor out of the synapse, stopping it from receiving information from other cells and making the cell less excitable.

The scientists who discovered SUMO's role say it is interesting because it means the receptor is not destroyed, but simply lies dormant, meaning the dangers of completely cutting off communication between cells should be avoided.

Professor Jeremy Henley, who led the research, said: "We have found one mechanism that regulates the flow of information between cells in the brain.

"It is possible that increasing the amount of SUMO attached to kainate receptors - which would red uce communication between the cells - could be a way to treat epilepsy by preventing over-excitation."

The researchers say that their findings could also provide insight into other brain diseases that are characterised by too much synaptic activity, like schizophrenia, which could one day lead to new drugs.

Professor Ley Sander, an epilepsy expert at the Institute of Neurology, said the work was at early stages but was interesting.

"This is an additional part of the puzzle and it is interesting to learn more about brain processes.

"But we are talking about five to 10 years if this is really going to make a big difference." Jo Loughran, of the mental health charity Rethink, said: "We welcome this exciting new research and hope that one day it could make a difference to the thousands of people living with severe mental illnesses like schizophrenia.

"We would like to see continued investment in such research that will lead to a third generation of antipsychotic medicines with fewer side effects."


'"/>




Related medicine news :

1. Designer baby for British couple
2. British Authorities Seize Spurious Drugs
3. Collaborations planned between British Organization and Indian health care industry
4. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
5. British Women Flies to India for Treatment of Breast Cancer
6. Sharp Increase In Morning-After Pill Sales Among British Women
7. British company developing ‘Safer Cigarettes
8. British man Recovered from HIV
9. British medical education suffers shortage of bodies
10. Relief For British MS Patients: Cannabis-Based Oral Spray
11. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... This week the The Voss Law Firm celebrates ... Bill Voss, the firm grew quickly and has built a reputation for excellence, trust, ... get the money they deserve from their insurance companies. , The Voss Law ...
(Date:8/23/2017)... ... August 23, 2017 , ... Earlier this month, the Workgroup for ... health IT to create efficiencies in healthcare information exchange and a trusted advisor to ... Forum which featured keynote addresses by Donald W. Rucker, MD, head of the ...
(Date:8/23/2017)... ... 23, 2017 , ... The Stevie® Awards have announced the winners of the Best of the ... business awards competition. , Nominees in the 2017 IBAs were not able to apply for ... on the total number of awards won in the IBAs with a Gold Stevie win ...
(Date:8/23/2017)... Lauderdale, FL (PRWEB) , ... August 23, 2017 ... ... firms for traveling medical professionals, recently launched a new website, http://www.cirrusmedicalstaffing.com . ... built to respond to the needs of healthcare professionals who are traveling on ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... has been named to the 2017 Inc. 500|5000, an exclusive ranking of America’s ... growth rate of 139 percent, marking the twelfth year that the company has ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... Mich., Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), ... the quarter ended June 30, 2017.  All comparisons, unless otherwise ... Second Quarter 2017 Highlights ... to $1,089 million, an increase of 3.5% ... Gross margin of 7.5% versus 7.6% ...
(Date:8/2/2017)... 2017 Fenita J. Caldwell ... Pinnacle Lifetime Professional in the Field of Healthcare. ... Turing Pharmaceuticals, AG. Her skills and areas of ... ... of experience as a highly successful sales specialist ...
(Date:7/31/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named ... by Crain,s Detroit Business . ... by three-year revenue growth. This year,s edition measures growth from ... view the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... triumph," said Phil Hagerman , CEO and chairman of ...
Breaking Medicine Technology: